vs
LIVEPERSON INC(LPSN)与RIGEL PHARMACEUTICALS INC(RIGL)财务数据对比。点击上方公司名可切换其他公司
RIGEL PHARMACEUTICALS INC的季度营收约是LIVEPERSON INC的1.2倍($69.8M vs $59.3M),RIGEL PHARMACEUTICALS INC净利率更高(384.0% vs -77.8%,领先461.8%),RIGEL PHARMACEUTICALS INC同比增速更快(21.2% vs -19.0%),过去两年RIGEL PHARMACEUTICALS INC的营收复合增速更高(53.7% vs -16.6%)
LivePerson是一家全球性科技企业,专注于开发对话式商务与人工智能软件,相关产品与解决方案能够帮助企业搭建智能对话体系,优化客户沟通体验,助力企业实现数字化商务运营转型。
Rigel制药是一家临床阶段生物技术企业,专注于研发及商业化针对自身免疫性疾病、炎症性疾病与血液疾病的靶向小分子疗法,核心市场位于美国,旗下已获批产品可治疗成人免疫性血小板减少症,致力于满足未被覆盖的临床医疗需求。
LPSN vs RIGL — 直观对比
营收规模更大
RIGL
是对方的1.2倍
$59.3M
营收增速更快
RIGL
高出40.2%
-19.0%
净利率更高
RIGL
高出461.8%
-77.8%
两年增速更快
RIGL
近两年复合增速
-16.6%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | ||
|---|---|---|
| 营收 | $59.3M | $69.8M |
| 净利润 | $-46.1M | $268.1M |
| 毛利率 | 73.2% | 91.5% |
| 营业利润率 | -68.7% | 33.2% |
| 净利率 | -77.8% | 384.0% |
| 营收同比 | -19.0% | 21.2% |
| 净利润同比 | 58.9% | 1769.2% |
| 每股收益(稀释后) | $-9.22 | $14.11 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比,按日历期对齐,财年错位的公司也能正确匹配
营收
LPSN
RIGL
| Q4 25 | $59.3M | $69.8M | ||
| Q3 25 | $60.2M | $69.5M | ||
| Q2 25 | $59.6M | $101.7M | ||
| Q1 25 | $64.7M | $53.3M | ||
| Q4 24 | $73.2M | $57.6M | ||
| Q3 24 | $74.2M | $55.3M | ||
| Q2 24 | $79.9M | $36.8M | ||
| Q1 24 | $85.1M | $29.5M |
净利润
LPSN
RIGL
| Q4 25 | $-46.1M | $268.1M | ||
| Q3 25 | $8.7M | $27.9M | ||
| Q2 25 | $-15.7M | $59.6M | ||
| Q1 25 | $-14.1M | $11.4M | ||
| Q4 24 | $-112.1M | $14.3M | ||
| Q3 24 | $-28.3M | $12.4M | ||
| Q2 24 | $41.8M | $-1.0M | ||
| Q1 24 | $-35.6M | $-8.2M |
毛利率
LPSN
RIGL
| Q4 25 | 73.2% | 91.5% | ||
| Q3 25 | 71.4% | 93.2% | ||
| Q2 25 | 69.7% | 95.6% | ||
| Q1 25 | 71.8% | 91.7% | ||
| Q4 24 | 77.4% | 89.9% | ||
| Q3 24 | 73.1% | 85.5% | ||
| Q2 24 | 79.4% | 92.4% | ||
| Q1 24 | 71.3% | 93.1% |
营业利润率
LPSN
RIGL
| Q4 25 | -68.7% | 33.2% | ||
| Q3 25 | -24.2% | 40.9% | ||
| Q2 25 | -10.8% | 60.1% | ||
| Q1 25 | -26.2% | 23.9% | ||
| Q4 24 | -138.0% | 28.9% | ||
| Q3 24 | -21.6% | 25.4% | ||
| Q2 24 | -37.3% | 1.2% | ||
| Q1 24 | -42.7% | -23.6% |
净利率
LPSN
RIGL
| Q4 25 | -77.8% | 384.0% | ||
| Q3 25 | 14.5% | 40.2% | ||
| Q2 25 | -26.4% | 58.6% | ||
| Q1 25 | -21.8% | 21.5% | ||
| Q4 24 | -153.2% | 24.9% | ||
| Q3 24 | -38.1% | 22.5% | ||
| Q2 24 | 52.3% | -2.8% | ||
| Q1 24 | -41.8% | -27.9% |
每股收益(稀释后)
LPSN
RIGL
| Q4 25 | $-9.22 | $14.11 | ||
| Q3 25 | $-2.76 | $1.46 | ||
| Q2 25 | $-0.17 | $3.28 | ||
| Q1 25 | $-0.24 | $0.63 | ||
| Q4 24 | $-17.23 | $0.82 | ||
| Q3 24 | $-4.74 | $0.70 | ||
| Q2 24 | $-0.33 | $-0.06 | ||
| Q1 24 | $-0.40 | $-0.47 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | ||
|---|---|---|
| 现金及短期投资手头流动性 | $95.0M | $155.0M |
| 总债务越低越好 | — | $52.5M |
| 股东权益账面价值 | $-44.5M | $391.5M |
| 总资产 | $454.7M | $513.6M |
| 负债/权益比越低杠杆越低 | — | 0.13× |
8季度趋势,按日历期对齐
现金及短期投资
LPSN
RIGL
| Q4 25 | $95.0M | $155.0M | ||
| Q3 25 | $106.7M | $137.1M | ||
| Q2 25 | $162.0M | $108.4M | ||
| Q1 25 | $176.3M | $77.1M | ||
| Q4 24 | $183.2M | $77.3M | ||
| Q3 24 | $142.1M | $61.1M | ||
| Q2 24 | $146.0M | $49.1M | ||
| Q1 24 | $127.1M | $49.5M |
总债务
LPSN
RIGL
| Q4 25 | — | $52.5M | ||
| Q3 25 | — | $60.0M | ||
| Q2 25 | — | $60.0M | ||
| Q1 25 | — | $60.0M | ||
| Q4 24 | — | $60.0M | ||
| Q3 24 | — | $60.0M | ||
| Q2 24 | — | $60.0M | ||
| Q1 24 | $512.1M | $60.0M |
股东权益
LPSN
RIGL
| Q4 25 | $-44.5M | $391.5M | ||
| Q3 25 | $-22.1M | $117.6M | ||
| Q2 25 | $-82.4M | $81.9M | ||
| Q1 25 | $-74.9M | $18.6M | ||
| Q4 24 | $-67.3M | $3.3M | ||
| Q3 24 | $45.9M | $-14.6M | ||
| Q2 24 | $66.6M | $-29.9M | ||
| Q1 24 | $19.2M | $-31.7M |
总资产
LPSN
RIGL
| Q4 25 | $454.7M | $513.6M | ||
| Q3 25 | $511.4M | $242.5M | ||
| Q2 25 | $604.2M | $206.7M | ||
| Q1 25 | $596.2M | $176.0M | ||
| Q4 24 | $607.8M | $164.0M | ||
| Q3 24 | $692.0M | $139.4M | ||
| Q2 24 | $703.8M | $128.4M | ||
| Q1 24 | $724.7M | $126.5M |
负债/权益比
LPSN
RIGL
| Q4 25 | — | 0.13× | ||
| Q3 25 | — | 0.51× | ||
| Q2 25 | — | 0.73× | ||
| Q1 25 | — | 3.23× | ||
| Q4 24 | — | 18.25× | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | 26.69× | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | ||
|---|---|---|
| 经营现金流最新季度 | $-9.7M | $22.0M |
| 自由现金流经营现金流 - 资本支出 | $-12.0M | — |
| 自由现金流率自由现金流/营收 | -20.2% | — |
| 资本支出强度资本支出/营收 | 3.9% | — |
| 现金转化率经营现金流/净利润 | — | 0.08× |
| 过去12个月自由现金流最近4个季度 | $-42.5M | — |
8季度趋势,按日历期对齐
经营现金流
LPSN
RIGL
| Q4 25 | $-9.7M | $22.0M | ||
| Q3 25 | $-6.0M | $24.0M | ||
| Q2 25 | $-11.7M | $30.5M | ||
| Q1 25 | $-3.1M | $-893.0K | ||
| Q4 24 | $-3.1M | $14.5M | ||
| Q3 24 | $4.8M | $21.7M | ||
| Q2 24 | $-17.9M | $302.0K | ||
| Q1 24 | $1.1M | $-5.0M |
自由现金流
LPSN
RIGL
| Q4 25 | $-12.0M | — | ||
| Q3 25 | $-8.9M | — | ||
| Q2 25 | $-14.8M | — | ||
| Q1 25 | $-6.9M | — | ||
| Q4 24 | $-6.8M | — | ||
| Q3 24 | $-230.0K | — | ||
| Q2 24 | $-22.9M | — | ||
| Q1 24 | $-10.4M | — |
自由现金流率
LPSN
RIGL
| Q4 25 | -20.2% | — | ||
| Q3 25 | -14.8% | — | ||
| Q2 25 | -24.9% | — | ||
| Q1 25 | -10.6% | — | ||
| Q4 24 | -9.2% | — | ||
| Q3 24 | -0.3% | — | ||
| Q2 24 | -28.7% | — | ||
| Q1 24 | -12.2% | — |
资本支出强度
LPSN
RIGL
| Q4 25 | 3.9% | — | ||
| Q3 25 | 4.8% | — | ||
| Q2 25 | 5.3% | — | ||
| Q1 25 | 5.8% | — | ||
| Q4 24 | 5.0% | — | ||
| Q3 24 | 6.8% | — | ||
| Q2 24 | 6.2% | — | ||
| Q1 24 | 13.5% | — |
现金转化率
LPSN
RIGL
| Q4 25 | — | 0.08× | ||
| Q3 25 | -0.69× | 0.86× | ||
| Q2 25 | — | 0.51× | ||
| Q1 25 | — | -0.08× | ||
| Q4 24 | — | 1.01× | ||
| Q3 24 | — | 1.75× | ||
| Q2 24 | -0.43× | — | ||
| Q1 24 | — | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
LPSN
| Hosted Services Business | $51.0M | 86% |
| Professional Services | $8.3M | 14% |
RIGL
暂无分部数据